These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Echocardiography to predict adverse cardiac and vascular events in patients with severe chronic kidney disease (stage 4): a prospective study. Lesaffre F; Wynckel A; Nazeyrollas P; Rieu P; Metz D Arch Cardiovasc Dis; 2013 Apr; 106(4):220-7. PubMed ID: 23706368 [TBL] [Abstract][Full Text] [Related]
27. Left ventricular remodeling and arterial remodeling in patients with chronic kidney disease stage 1-3. Pluta A; Stróżecki P; Krintus M; Odrowąż-Sypniewska G; Manitius J Ren Fail; 2015 Aug; 37(7):1105-10. PubMed ID: 26156686 [TBL] [Abstract][Full Text] [Related]
28. A look at the upper heart chamber: the left atrium in chronic kidney disease. Paoletti E; Zoccali C Nephrol Dial Transplant; 2014 Oct; 29(10):1847-53. PubMed ID: 24286975 [TBL] [Abstract][Full Text] [Related]
29. [Cardioprotection: an essential component for predialysis chronic renal failure treatment]. Jungers P; Qualim Z; Nguyen-Khoa T; Massy Z; London G Nephrologie; 2003; 24(2):79-88. PubMed ID: 12723513 [TBL] [Abstract][Full Text] [Related]
30. What happens to the heart in chronic kidney disease? Rutherford E; Mark PB J R Coll Physicians Edinb; 2017 Mar; 47(1):76-82. PubMed ID: 28569289 [TBL] [Abstract][Full Text] [Related]
36. Pulmonary hypertension: epidemiology in different CKD stages and its association with cardiovascular morbidity. Li Z; Liang X; Liu S; Ye Z; Chen Y; Wang W; Li R; Xu L; Feng Z; Shi W PLoS One; 2014; 9(12):e114392. PubMed ID: 25525807 [TBL] [Abstract][Full Text] [Related]
37. Cardiac imaging in patients with chronic kidney disease. Chiu DY; Green D; Abidin N; Sinha S; Kalra PA Nat Rev Nephrol; 2015 Apr; 11(4):207-20. PubMed ID: 25561081 [TBL] [Abstract][Full Text] [Related]
38. Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations. Law JP; Pickup L; Pavlovic D; Townend JN; Ferro CJ J Hum Hypertens; 2023 Jan; 37(1):1-19. PubMed ID: 36138105 [TBL] [Abstract][Full Text] [Related]
39. Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). Charytan DM; Lewis EF; Desai AS; Weinrauch LA; Ivanovich P; Toto RD; Claggett B; Liu J; Hartley LH; Finn P; Singh AK; Levey AS; Pfeffer MA; McMurray JJ; Solomon SD Am J Kidney Dis; 2015 Sep; 66(3):429-40. PubMed ID: 25935581 [TBL] [Abstract][Full Text] [Related]
40. Imaging of Myocardial Fibrosis in Patients with End-Stage Renal Disease: Current Limitations and Future Possibilities. Graham-Brown MP; Patel AS; Stensel DJ; March DS; Marsh AM; McAdam J; McCann GP; Burton JO Biomed Res Int; 2017; 2017():5453606. PubMed ID: 28349062 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]